LPC
TGTX icon

Lion Point Capital’s TG Therapeutics TGTX Stock Holding History

Lion Point Capital’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,160,307
Closed -$22M – 37
2021
Q4 		$22M Buy
1,160,307
+321,179
+38% +$8.34M 5.91% 6
2021
Q3 		$27.9M Buy
839,128
+230,000
+38% +$7.12M 5.24% 6
2021
Q2 		$23.6M Hold
609,128
– – 4.08% 10
2021
Q1 		$29.4M Sell
609,128
-718,606
-54% -$34.5M 5.34% 9
2020
Q4 		$69.1M Hold
1,327,734
– – 13.3% 1
2020
Q3 		$35.5M Buy
1,327,734
+429,935
+48% +$9.89M 7.79% 3
2020
Q2 		$17.5M Buy
+897,799
New +$14.5M 4.24% 10

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return